Found: 38
Select item for more details and to access through your institution.
Anti–Valosin‐Containing Protein (VCP/p97) Autoantibodies in Inclusion Body Myositis and Other Inflammatory Myopathies.
- Published in:
- ACR Open Rheumatology, 2023, v. 5, n. 1, p. 10, doi. 10.1002/acr2.11510
- By:
- Publication type:
- Article
Acceptability of an Adolescent Self‐Management Program for Juvenile Idiopathic Arthritis.
- Published in:
- ACR Open Rheumatology, 2022, v. 4, n. 2, p. 142, doi. 10.1002/acr2.11373
- By:
- Publication type:
- Article
Purpura, petechiae, and bullae as first signs of juvenile granulomatosis with polyangiitis.
- Published in:
- European Journal of Pediatrics, 2014, v. 173, n. 12, p. 1685, doi. 10.1007/s00431-014-2298-2
- By:
- Publication type:
- Article
Synovial fluid mesenchymal progenitor cells from patients with juvenile idiopathic arthritis demonstrate limited self-renewal and chondrogenesis.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-20880-7
- By:
- Publication type:
- Article
Patient factors associated with waiting time to pediatric rheumatologist consultation for patients with juvenile idiopathic arthritis.
- Published in:
- Pediatric Rheumatology, 2020, v. 18, n. 1, p. 1, doi. 10.1186/s12969-020-0413-7
- By:
- Publication type:
- Article
Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.00745
- By:
- Publication type:
- Article
Relationship of Fatigue, Pain Interference, and Physical Disability in Children Newly Diagnosed With Juvenile Idiopathic Arthritis.
- Published in:
- Arthritis Care & Research, 2024, v. 76, n. 10, p. 1409, doi. 10.1002/acr.25377
- By:
- Publication type:
- Article
Parent‐Reported Medication Side Effects and Their Impact on Health‐Related Quality of Life in Children With Juvenile Idiopathic Arthritis.
- Published in:
- Arthritis Care & Research, 2022, v. 74, n. 10, p. 1567, doi. 10.1002/acr.24610
- By:
- Publication type:
- Article
Functional Ability and Health-Related Quality of Life in Randomized Controlled Trials of Tocilizumab in Patients With Juvenile Idiopathic Arthritis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Clinical Characteristics of Children With Juvenile Dermatomyositis: The Childhood Arthritis and Rheumatology Research Alliance Registry.
- Published in:
- Arthritis Care & Research, 2014, v. 66, n. 3, p. 404, doi. 10.1002/acr.22142
- By:
- Publication type:
- Article
Consensus treatments for moderate Juvenile Dermatomyositis: Beyond the first two months. Results of the Second Childhood Arthritis and Rheumatology Research Alliance Consensus Conference.
- Published in:
- Arthritis Care & Research, 2012, v. 64, n. 4, p. 546, doi. 10.1002/acr.20695
- By:
- Publication type:
- Article
Clinical Characteristics of Adolescents With Juvenile Idiopathic Arthritis Transitioning to Adult Rheumatology Care in Canada: Results From the CAPRI Registry.
- Published in:
- Journal of Rheumatology, 2024, v. 51, n. 4, p. 403, doi. 10.3899/jrheum.2023-0783
- By:
- Publication type:
- Article
Growth During Tocilizumab Therapy for Polyarticular-course Juvenile Idiopathic Arthritis: 2-year Data from a Phase III Clinical Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Management of Juvenile Idiopathic Arthritis 2015: A Position Statement from the Pediatric Committee of the Canadian Rheumatology Association.
- Published in:
- 2016
- By:
- Publication type:
- Editorial
Development of System-level Performance Measures for Evaluation of Models of Care for Inflammatory Arthritis in Canada.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Development and validation of the Kids Disability Screen for children with juvenile idiopathic arthritis: results from the CAPRI Registry.
- Published in:
- Rheumatology, 2022, v. 61, n. 12, p. 4835, doi. 10.1093/rheumatology/keac146
- By:
- Publication type:
- Article
Impact of the COVID-19 pandemic on juvenile idiopathic arthritis presentation and research recruitment: results from the CAPRI registry.
- Published in:
- Rheumatology, 2022, v. 61, p. SI157, doi. 10.1093/rheumatology/keab812
- By:
- Publication type:
- Article
Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis.
- Published in:
- Rheumatology, 2021, v. 60, n. 10, p. 4568, doi. 10.1093/rheumatology/keab047
- By:
- Publication type:
- Article
Open-label phase 3 study of intravenous golimumab in patients with polyarticular juvenile idiopathic arthritis.
- Published in:
- Rheumatology, 2021, v. 60, n. 10, p. 4495, doi. 10.1093/rheumatology/keab021
- By:
- Publication type:
- Article
Risk factors associated with Pneumocystis jirovecii pneumonia in juvenile myositis in North America.
- Published in:
- Rheumatology, 2021, v. 60, n. 2, p. 829, doi. 10.1093/rheumatology/keaa436
- By:
- Publication type:
- Article
The iCanCope pain self-management application for adolescents with juvenile idiopathic arthritis: a pilot randomized controlled trial.
- Published in:
- Rheumatology, 2021, v. 60, n. 1, p. 196, doi. 10.1093/rheumatology/keaa178
- By:
- Publication type:
- Article
A new Canadian inception cohort for juvenile idiopathic arthritis: The Canadian Alliance of Pediatric Rheumatology Investigators Registry.
- Published in:
- Rheumatology, 2020, v. 59, n. 10, p. 2796, doi. 10.1093/rheumatology/keaa006
- By:
- Publication type:
- Article
170 Safety and efficacy of subcutaneous tocilizumab in patients with systemic and polyarticular juvenile idiopathic arthritis.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
Nailfold capillary density is importantly associated over time with muscle and skin disease activity in juvenile dermatomyositis.
- Published in:
- Rheumatology, 2011, v. 50, n. 5, p. 885, doi. 10.1093/rheumatology/keq407
- By:
- Publication type:
- Article
Distinct phenotypes of multisystem inflammatory syndrome in children: a cohort study.
- Published in:
- Pediatric Rheumatology, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12969-023-00815-w
- By:
- Publication type:
- Article
Testing population-based performance measures identifies gaps in juvenile idiopathic arthritis (JIA) care.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Patient‐Reported Barriers at School for Children with Juvenile Idiopathic Arthritis.
- Published in:
- ACR Open Rheumatology, 2019, v. 1, n. 3, p. 182, doi. 10.1002/acr2.1023
- By:
- Publication type:
- Article
Association with HLA-DRβ1 position 37 distinguishes juvenile dermatomyositis from adult-onset myositis.
- Published in:
- Human Molecular Genetics, 2022, v. 31, n. 14, p. 2471, doi. 10.1093/hmg/ddac019
- By:
- Publication type:
- Article
Efficacy and Safety of Adalimumab as the First and Second Biologic Agent in Juvenile Idiopathic Arthritis: The German Biologics JIA Registry.
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, n. 9, p. 2580, doi. 10.1002/art.38741
- By:
- Publication type:
- Article
A38: Twelve Years' Experience with Etanercept in the Treatment of Juvenile Idiopathic Arthritis: How It Has Changed Practice-The German Biologics JIA Registry (BiKeR)
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
A11: Assessment of Radiographic Progression in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis Treated With Tocilizumab: 2-Year Data From CHERISH.
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, p. S17, doi. 10.1002/art.38422
- By:
- Publication type:
- Article
A39: Efficacy and Safety of Methotrexate in Oligoarticular Persistent Juvenile Idiopathic Arthritis.
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, p. S59, doi. 10.1002/art.38455
- By:
- Publication type:
- Article
A38: Twelve Years' Experience with Etanercept in the Treatment of Juvenile Idiopathic Arthritis: How It Has Changed Practice-The German Biologics JIA Registry (BiKeR).
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, p. S58, doi. 10.1002/art.38454
- By:
- Publication type:
- Article
Quantitative Assessment of Immediate Cutaneous Hypersensitivity in a Model of Genetic Predisposition to Atopy.
- Published in:
- International Archives of Allergy & Immunology, 1998, v. 117, n. 4, p. 239, doi. 10.1159/000024017
- By:
- Publication type:
- Article
Evaluation of Real-World Healthcare Resource Utilization and Associated Costs in Children with Juvenile Idiopathic Arthritis: A Canadian Retrospective Cohort Study.
- Published in:
- Rheumatology & Therapy, 2021, v. 8, n. 3, p. 1303, doi. 10.1007/s40744-021-00331-x
- By:
- Publication type:
- Article
A Canadian evaluation framework for quality improvement in childhood arthritis: key performance indicators of the process of care.
- Published in:
- Arthritis Research & Therapy, 2020, v. 22, n. 1, p. 1, doi. 10.1186/s13075-020-02151-w
- By:
- Publication type:
- Article
Tumour necrosis factor alpha promoter polymorphisms and etanercept therapy in juvenile idiopathic arthritis.
- Published in:
- Rheumatology International, 2007, v. 27, n. 4, p. 383, doi. 10.1007/s00296-006-0208-2
- By:
- Publication type:
- Article
Infliximab in two patients with juvenile ankylosing spondylitis.
- Published in:
- Rheumatology International, 2004, v. 24, n. 3, p. 173, doi. 10.1007/s00296-003-0378-0
- By:
- Publication type:
- Article